
<script type="text/javascript">
<!--
document.write('<div id="oa_widget"></div>');
document.write('<script type="text/javascript" src="https://www.openaire.eu/index.php?option=com_openaire&view=widget&format=raw&projectId=undefined&type=result"></script>');
-->
</script>The neuroacanthocytoses are a group of disorders characterised by peripheral blood acanthocytes, central nervous system as well as neuromuscular symptoms. These disorders uniformly result in pathology in the basal ganglia, which account for the characteristic motor symptoms such as chorea or dystonia, but may also account for the apparent elevated rates of major mental disorders in these syndromes. Elevated rates of dysexecutive syndromes, obsessive-compulsive disorder, depression and schizophrenia-like psychosis appear to occur in chorea-acanthocytosis, McLeod's syndrome, pantothenate kinase-associated neurodegeneration, and Huntington's disease-like 2. Disruptions to key frontostriatal loops secondary to pathology in the striatum and pallidum appear to predispose individuals to major neuropsychiatric syndromes; however, treatment can be instituted for a number of these manifestations, which lessens the overall burden of disease in neuroacanthocytosis patients and their families.
anti Chorea-acanthocytosis, 2805 Cognitive Neuroscience, neuroleptic agent, olanzapine, 610 Medicine & health, haloperidol, Striatum, Keywords: aripiprazole, 3206 Neuropsychology and Physiological Psychology, thioridazine, 2802 Behavioral Neuroscience, Obsessive-compulsive disorder, Humans, dopamine receptor blocking agent, chlorpromazine, Executive impairment, risperidone, clozapine, trifluoperazine, Mental Disorders, Brain, adjuvant therapy, quetiapine, Neuropsychiatry, 10040 Clinic for Neurology, serotonin uptake inhibitor, Schizophrenia, atypical antipsychotic agent, McLeod syndrome, Neuroacanthocytosis
anti Chorea-acanthocytosis, 2805 Cognitive Neuroscience, neuroleptic agent, olanzapine, 610 Medicine & health, haloperidol, Striatum, Keywords: aripiprazole, 3206 Neuropsychology and Physiological Psychology, thioridazine, 2802 Behavioral Neuroscience, Obsessive-compulsive disorder, Humans, dopamine receptor blocking agent, chlorpromazine, Executive impairment, risperidone, clozapine, trifluoperazine, Mental Disorders, Brain, adjuvant therapy, quetiapine, Neuropsychiatry, 10040 Clinic for Neurology, serotonin uptake inhibitor, Schizophrenia, atypical antipsychotic agent, McLeod syndrome, Neuroacanthocytosis
| citations This is an alternative to the "Influence" indicator, which also reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically). | 45 | |
| popularity This indicator reflects the "current" impact/attention (the "hype") of an article in the research community at large, based on the underlying citation network. | Top 10% | |
| influence This indicator reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically). | Top 10% | |
| impulse This indicator reflects the initial momentum of an article directly after its publication, based on the underlying citation network. | Top 10% |
